Suchergebnisse - "Garrido-Laguna, Ignacio"

PubPharm (8)

1

Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer

enthalten in: The New England journal of medicine | 2023

von Strickler, J. | Satake, H. | George, T. | +19

CommentIn: Transl Cancer Res. 2023 Dec 31;12(12):3227-3232. - PMID 38197074

2

Pancreatic cancer : from state-of-the-art treatments to promising novel therapies

enthalten in: Nature reviews. Clinical oncology | 2015

von Garrido-Laguna, I. | Hidalgo, M.

3

Targeted therapy for genetic cancer syndromes : Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathies

enthalten in: Discovery medicine | 2015

von Agarwal, R. | Liebe, S. | Turski, M. | +9

4

PIK3CA mutations in advanced cancers : characteristics and outcomes

enthalten in: Oncotarget | 2012

von Janku, F. | Wheler, J. | Naing, A. | +11

CommentIn: Cell Cycle. 2013 Jun 15;12(12):1817-8. - PMID 23708510

5

KRASness and PIK3CAness in patients with advanced colorectal cancer : outcome after treatment with early-phase trials with targeted pathway inhibitors

enthalten in: PloS one | 2012

von Garrido-Laguna, I. | Hong, D. | Janku, F. | +8

6

Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models

enthalten in: Cancer biology & therapy | 2011

von Feldmann, G. | Mishra, A. | Bisht, S. | +14

7

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors

enthalten in: Molecular cancer therapeutics | 2011

von Janku, F. | Tsimberidou, A. | Garrido-Laguna, I. | +11

CommentIn: Pharmacogenomics. 2011 Oct;12(10):1382. - PMID 22121542

8

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers

enthalten in: PloS one | 2011

von Janku, F. | Lee, J. | Tsimberidou, A. | +7

1
[1]